Extract
Antigenics Reports First Quarter 2008 Financial Results.
Conference Call to Follow
NEW YORK -- Antigenics Inc. (NASDAQ: AGEN) reported results today for the quarter ended March 31, 2008. The company incurred a net loss attributable to common stockholders of $11.3 million, or $0.20 per share, basic and diluted, for the first quarter of 2008, compared with a net loss attributable to common stockholders in the first quarter of 2007 of $8.9 million, or $0.19 per share, basic...See the full content of this document
Sponsored links
